Hasil Pencarian (1)
small molecule | CAS: 901119-35-5
Fostamatinib has been investigated for the treatment and basic science of Rheumatoid Arthritis and Immune Thrombocytopenic Purpura (ITP). It was approved on April 17, 2018, under the trade name Tavalisse for use in ITP [L2644, FDA Label]. Fostamatinib has als…
Kategori:
AminesBCRP/ABCG2 InhibitorsBlood and Blood Forming Organs
+17
Target Protein:
Tyrosine-protein kinase SYKAdenosine receptor A3Synaptic vesicular amine transporter
+297
Waktu ParuhR406 has a half-lif…
Vol. DistribusiR406 has an apparen…
KlirensR406 has an apparen…
Genetik
-